Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2025-12-27 @ 10:39 PM
Study NCT ID:
NCT06081595
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-13
First Post:
2023-10-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment
Sponsor:
Jin Li
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-07
First Submit QC Date:
None
Study First Post Date:
2023-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-07
Last Update Post Date:
2023-10-13
Last Update Post Date Type:
ACTUAL